Ebola booster vaccine trial to combine GSK, Emergent Bio shots
March 16, 2015 at 08:11 AM EDT
LONDON, March 16 (Reuters) - Scientists are to test a new two-shot Ebola vaccine using an experimental shot from Britain's GlaxoSmithKline, which is already in clinical trials in Africa, and a new kind of booster from Emergent BioSolutions .